Relay Therapeutics Inc (RLAY)
4.75
+0.11
(+2.37%)
USD |
NASDAQ |
Nov 22, 16:00
4.74
-0.01
(-0.21%)
Pre-Market: 20:00
Relay Therapeutics Total Liabilities (Quarterly): 91.25M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 91.25M |
| June 30, 2024 | 90.81M |
| March 31, 2024 | 95.68M |
| December 31, 2023 | 91.98M |
| September 30, 2023 | 128.59M |
| June 30, 2023 | 151.90M |
| March 31, 2023 | 154.15M |
| December 31, 2022 | 149.55M |
| September 30, 2022 | 168.95M |
| June 30, 2022 | 109.78M |
| Date | Value |
|---|---|
| March 31, 2022 | 107.91M |
| December 31, 2021 | 110.64M |
| September 30, 2021 | 100.53M |
| June 30, 2021 | 95.87M |
| March 31, 2021 | 38.56M |
| December 31, 2020 | 36.54M |
| September 30, 2020 | 38.16M |
| June 30, 2020 | 573.43M |
| March 31, 2020 | 34.84M |
| December 31, 2019 | 573.51M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
34.84M
Minimum
Mar 2020
573.51M
Maximum
Dec 2019
147.13M
Average
104.22M
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| Summit Therapeutics Inc | 64.93M |
| Biomarin Pharmaceutical Inc | 1.438B |
| Lexicon Pharmaceuticals Inc | 142.61M |
| Arbutus Biopharma Corp | 33.55M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 930.12M |
| Shareholders Equity (Quarterly) | 838.86M |